Journey Medical Corporati... (DERM)
Journey Medical Statistics
Share Statistics
Journey Medical has 20.89M shares outstanding. The number of shares has increased by 12.87% in one year.
| Shares Outstanding | 20.89M |
| Shares Change (YoY) | 12.87% |
| Shares Change (QoQ) | 0.78% |
| Owned by Institutions (%) | 18.41% |
| Shares Floating | 14.32M |
| Failed to Deliver (FTD) Shares | 355 |
| FTD / Avg. Volume | 0.59% |
Short Selling Information
The latest short interest is 78.74K, so 0.38% of the outstanding shares have been sold short.
| Short Interest | 78.74K |
| Short % of Shares Out | 0.38% |
| Short % of Float | 0.55% |
| Short Ratio (days to cover) | 1.26 |
Valuation Ratios
The PE ratio is -27.26 and the forward PE ratio is -67.67. Journey Medical's PEG ratio is 0.31.
| PE Ratio | -27.26 |
| Forward PE | -67.67 |
| PS Ratio | 1.33 |
| Forward PS | 0.7 |
| PB Ratio | 5.16 |
| P/FCF Ratio | 437.58 |
| PEG Ratio | 0.31 |
Enterprise Valuation
Journey Medical Corporation has an Enterprise Value (EV) of 95.31M.
| EV / Earnings | -24.74 |
| EV / Sales | 1.2 |
| EV / EBITDA | 49.61 |
| EV / EBIT | -45.98 |
| EV / FCF | 397.12 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.87.
| Current Ratio | 1.35 |
| Quick Ratio | 1.1 |
| Debt / Equity | 0.87 |
| Total Debt / Capitalization | 46.56 |
| Cash Flow / Debt | 0.3 |
| Interest Coverage | -1.22 |
Financial Efficiency
Return on equity (ROE) is -0.19% and return on capital (ROIC) is -5.78%.
| Return on Equity (ROE) | -0.19% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -5.78% |
| Revenue Per Employee | $1,931,243.9 |
| Profits Per Employee | $-93,975.61 |
| Employee Count | 41 |
| Asset Turnover | 1.03 |
| Inventory Turnover | 2.61 |
Taxes
| Income Tax | 221K |
| Effective Tax Rate | -0.06 |
Stock Price Statistics
The stock price has increased by 64.4% in the last 52 weeks. The beta is 0.98, so Journey Medical's price volatility has been higher than the market average.
| Beta | 0.98 |
| 52-Week Price Change | 64.4% |
| 50-Day Moving Average | 5.02 |
| 200-Day Moving Average | 5.19 |
| Relative Strength Index (RSI) | 58.05 |
| Average Volume (20 Days) | 60.07K |
Income Statement
In the last 12 months, Journey Medical had revenue of 79.18M and earned -3.85M in profits. Earnings per share was -0.21.
| Revenue | 79.18M |
| Gross Profit | 52.52M |
| Operating Income | -2.07M |
| Net Income | -3.85M |
| EBITDA | 1.92M |
| EBIT | -2.07M |
| Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 27.44M in cash and 17.73M in debt, giving a net cash position of 9.71M.
| Cash & Cash Equivalents | 27.44M |
| Total Debt | 17.73M |
| Net Cash | 9.71M |
| Retained Earnings | -72.36M |
| Total Assets | 64.04M |
| Working Capital | 12.83M |
Cash Flow
In the last 12 months, operating cash flow was 5.24M and capital expenditures -5M, giving a free cash flow of 240K.
| Operating Cash Flow | 5.24M |
| Capital Expenditures | -5M |
| Free Cash Flow | 240K |
| FCF Per Share | 0.01 |
Margins
Gross margin is 66.33%, with operating and profit margins of -2.62% and -4.87%.
| Gross Margin | 66.33% |
| Operating Margin | -2.62% |
| Pretax Margin | -4.59% |
| Profit Margin | -4.87% |
| EBITDA Margin | 2.43% |
| EBIT Margin | -2.62% |
| FCF Margin | 0.3% |
Dividends & Yields
DERM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -3.47% |
| FCF Yield | 0.19% |
Analyst Forecast
The average price target for DERM is $10, which is 65.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 65.3% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Scores
| Altman Z-Score | -0.1 |
| Piotroski F-Score | 1 |